Pilot Evaluation of Two <i>Fasciola hepatica</i> Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics

Pilot Evaluation of Two <i>Fasciola hepatica</i> Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics

<i>Fasciola hepatica</i>, the causative agent of fasciolosis, is a global threat to public health, animal welfare, agricultural productivity, and food security. In the ongoing absence of a commercial vaccine, independent emergences of anthelmintic-resistant parasite populations worldwide...

Full description

Bibliographic Details
Main Authors: Clare F. Collett, Russell M. Morphew, David Timson, Helen C. Phillips, Peter M. Brophy
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Molecules
Subjects:
fasciolosis
triclabendazole
diagnostics
biomarker
calreticulin
triose phosphate isomerase
Online Access:https://www.mdpi.com/1420-3049/25/15/3477

Internet

https://www.mdpi.com/1420-3049/25/15/3477

Similar Items